FDA Inspection 800541 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 2077837

The FDA completed an inspection of Octapharma Plasma Inc on September 13, 2012 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 13, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Diego, CA (United States)